Martin Shkreli, former CEO of Turing Pharmaceuticals, leaves a U.S. Federal courthouse following an arraignment on charges of securities fraud in New York, on Dec. 17, 2015.
Andrew Gombert—EPA
By Tessa Berenson
January 8, 2016

Martin Shkreli is worth at least $45 million, according to newly released court filing.

According to the New York Times, a court filling disclosed by federal prosecutors Thursday shows that a brokerage account containing $45 million was used to secure the $5 million bond posted by Shkreli after his Dec. 17 arrest.

The Times says this brokerage account at E-Trade is the first public accounting of how much money Shkreli,the Turing Pharmaceuticals CEO who became infamous for raising the price of a life-saving pill from $13.50 to $750, has made.

Shkreli was arrested in December for securities fraud.

 

Write to Tessa Berenson at tessa.berenson@time.com.

SPONSORED FINANCIAL CONTENT

Read More From TIME

EDIT POST